Used as a potent anti-inflammatory agent, particularly in the development of treatments for autoimmune and inflammatory diseases. It functions as a selective inhibitor of Janus kinase (JAK), specifically targeting JAK1 and JAK2 pathways, which play key roles in cytokine signaling. This compound is investigated for use in conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease due to its ability to modulate immune responses. Its structure allows for improved selectivity and reduced off-target effects, making it a candidate for oral therapeutics with enhanced efficacy and safety profiles.